JYours
JYours, founded in 2023, is a technology company specializing in Artificial Intelligence (AI) and Quantum Mechanics (QM) for the pharmaceutical and new materials industries. They leverage advanced AI algorithms, including deep learning and machine learning, alongside quantum mechanics models to accelerate drug discovery and development. Their core offerings include an AI-driven drug discovery platform that enhances virtual screening, molecule design, and prediction of molecular properties. JYours aims to address traditional pharmaceutical pain points such as low success rates and high costs by providing intelligent solutions for various stages of drug development, from target discovery to clinical trial optimization. Their technology integrates with multi-omics data and focuses on areas like small molecule drug design, RNA drug development, and medical image analysis.
JYours
JYours, founded in 2023, is a technology company specializing in Artificial Intelligence (AI) and Quantum Mechanics (QM) for the pharmaceutical and new materials industries. They leverage advanced AI algorithms, including deep learning and machine learning, alongside quantum mechanics models to accelerate drug discovery and development. Their core offerings include an AI-driven drug discovery platform that enhances virtual screening, molecule design, and prediction of molecular properties. JYours aims to address traditional pharmaceutical pain points such as low success rates and high costs by providing intelligent solutions for various stages of drug development, from target discovery to clinical trial optimization. Their technology integrates with multi-omics data and focuses on areas like small molecule drug design, RNA drug development, and medical image analysis.